For Dr. Raymond Hakim, MDCM’76, McGill has always been a family affair. His brother is a neurologist who worked for many years at the Montreal Neurological Institute, and his sister earned a Bachelor of Science from McGill in 1974. More recently, Dr. Hakim’s two nieces attended McGill, both earning degrees from the Faculty of Science.
Dr. Hakim himself is now the chief medical officer and senior executive vice-president of Fresenius Medical Care North America, the largest integrated provider of products and services for individuals with chronic kidney failure, a condition that affects more than 1.4 million individuals worldwide.
Yet despite living in
“The Catherine McLaughlin Hakim Chair comes at a time when the Faculty of Medicine is experiencing unprecedented growth and is garnering international attention for its many achievements in teaching and research,” says the Faculty’s Dean, Dr. Richard Levin.
The first holder of the chair is Dr. Andrey V. Cybulsky, Professor of Medicine and Director of the Nephrology Division, which provides patient care, conducts research and oversees teaching in the diagnosis and treatment of kidney disease.
“I sincerely thank Dr. Hakim and his family for their generous support. The endowment they have created will enhance the profile of the Nephrology Division and help us maintain and acquire the expertise needed to fight chronic kidney disease and end-stage renal failure,” says Dr. Cybulsky.
An estimated two million Canadians have kidney disease or are at risk of developing the illness. Each day, about 14 Canadians learn that their kidneys have failed — a condition that can prove fatal if not treated immediately. The Catherine McLaughlin Hakim chair will provide a major boost to Canadian research in this important field and ensure that McGill leads the way.
Nov. 14, 2007 at 12:12 PM